The Double-Edge Sword of CRISPR Application for In Vivo Studies | Oncotarget

5 views

|

November 27, 2023

  • Share
  • Oncotarget published this editorial on November 27, 2023 in Volume 14, entitled, “The double-edge sword of CRISPR application for in vivo studies” by Martin K. Thomsen from the Department of Biomedicine, Aarhus University, Aarhus C 8000, Denmark. DOI - https://doi.org/10.18632/oncotarget.28459 Correspondence to - Martin K. Thomsen - mkt@biomed.au.dk Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28459 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, CRISPR, in vivo, mouse models, Adenoassociated virus About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

    Cancer ResearchCell Science

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.